Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
This is a study to assess the combination of PXD101 and 5-Fluorouracil (5-FU)in patients with
advanced solid tumors. The primary goal of the study is to understand the safety, anti-tumor
activity, and how the study drug behaves within the body when given with 5-Fluorouracil
(5-FU).